Can AI Prioritize a Denial Worklist by Revenue at Risk? The 5-Factor Score

TLDR: Can AI prioritize a denial worklist by revenue at risk? Yes, but only when the ordering rule is designed first and the five inputs it needs (payer window, deadline proximity, revenue exposure, clinical readiness, appeal probability) exist as validated fields. First-in-first-out worklists lose winnable appeals to expired deadlines while staff work claims that were never going to pay. The redesign is the scoring rule; AI is what recomputes it every night at volume.

Best For: VPs and SVPs of Revenue Cycle and Directors of RCM or Payer Operations at US provider, lab, and diagnostics enterprises (1,000 to 15,000 employees) whose write-off number just reached the CFO and who need to show a queue redesign, not a faster version of the same queue.

A revenue-at-risk denial worklist is a work queue that orders denied claims by the revenue a provider is likely to lose if nobody acts before the payer's deadline, instead of by the date the denial arrived. The distinction sounds small. In practice it decides which appeals get written and which expire. Most denial teams still work first-in-first-out, because that is how the clearinghouse delivers the list and how the billing system displays it. The team is busy. The overturn rate looks fine. And the out-of-window write-off line keeps growing anyway. This post lays out the ordering rule that replaces arrival date, the five inputs it needs, what AI can and cannot do with each, and how to pilot the redesign on one payer before anyone asks for platform budget.

Can AI Prioritize a Denial Worklist by Revenue at Risk?

AI can prioritize a denial worklist by revenue at risk when five inputs exist as validated fields on every denied claim: the payer's appeal window, the days remaining in it, the expected reimbursement, whether the clinical documentation needed for the appeal is already in hand, and the historical overturn rate for that payer and denial reason. Where those fields exist, AI recomputes the ranking daily and routes work. Where they do not, AI ranks noise.

What first-in-first-out actually optimizes for

First-in-first-out optimizes for fairness to the claim, not for recovered revenue. Every denial waits its turn regardless of value or deadline. That made sense when denial volumes were low enough that the whole queue cleared within the shortest payer window. Volumes stopped being that low some time ago. Experian Health's 2025 State of Claims survey found 41% of providers now see at least one in ten claims denied, and 54% say denials are still rising. Kodiak Solutions' 2025 data from more than 2,300 hospitals showed the median final denial rate climbing from 2.5% to 2.7% in a single year, with net revenue leakage up roughly 25%.

When the queue is longer than the team can clear inside the shortest deadline, arrival order becomes a lottery. Whichever claims happened to land early get worked. Whichever claims had 65 days instead of 180 get worked too late.

What revenue at risk means in a denial queue

Revenue at risk is the expected reimbursement on a denied claim multiplied by the probability it can still be recovered, discounted by how little time remains to try. Three claims with identical balances carry very different revenue at risk if one has 40 days left with a payer that overturns 55% of appeals, one has 170 days left with the same payer, and one has 12 days left with a payer that overturns 20% and the clinical notes are missing. A first-in-first-out list treats them as equals. A revenue-at-risk list does not.

How the thinking moved from volume to value

Denial management grew up as a volume discipline: count the denials, count the appeals, report the overturn rate. The overturn rate is a flattering metric because it only measures the claims the team chose to appeal. KFF's 2024 analysis of ACA marketplace plans found insurers denied about 19% of in-network claims and fewer than 1% of those denials were ever appealed. The revenue sitting in unappealed denials dwarfs the revenue sitting in lost appeals. Over the last three years the better revenue cycle teams moved the conversation from "how many did we win" to "how much did we leave on the table and why," which is the shift that makes revenue-at-risk ordering the natural next step. Assembly's three-column map of what AI can and cannot fix in claim denials covers the broader boundary; this post is about the queue.

Why First-In-First-Out Fails on Today's Denial Volumes

First-in-first-out fails because the denial queue is now longer than the shortest payer appeal window, so arrival order quietly decides which winnable appeals expire. Three things are going on at once: there are more denials than staff can work, deadlines vary by payer from about two months to a year, and a growing share of denials need clinical documentation the team does not have yet.

The volume problem

Denial volume outgrew the team years ago. AKASA's survey of 556 hospital CFOs and revenue cycle leaders found 76% named denials management the most time-consuming task in the revenue cycle, ahead of prior authorization at 60%. MGMA's March 2024 Stat poll found 60% of medical group leaders reporting higher denial rates than the prior year. Hiring did not keep pace, and the AHA reported in 2024 that commercial denials rose 20.2% and Medicare Advantage denials rose 55.7% between 2022 and 2023.

The deadline problem

Appeal windows are not uniform, and the queue does not know that. CMS rules for Medicare Advantage give 65 calendar days from the denial notice to request reconsideration, and the plan then has up to 60 days to decide a payment appeal. Commercial contracts often allow 180 days; some allow less. A first-in-first-out queue puts a 65-day Medicare Advantage denial behind a 180-day commercial denial simply because the commercial one arrived on Tuesday and the Medicare Advantage one on Wednesday.

The expiry problem

The share of revenue that never comes back is the number the CFO is now looking at. HFMA's summary of Crowe's 2023 benchmarking estimated that about 8% of revenue billed to commercial payers is never received or is later taken back. Kodiak's December 2023 benchmarking showed commercial accounts receivable aged past 90 days rising from 27% to 36% of claim value between 2020 and 2023. Aged receivables are where deadlines die. A claim that crosses its appeal window while sitting in position 400 of a first-in-first-out list is a write-off the organization chose. Nobody meant to choose it, but the queue did.

First-In-First-Out vs. Revenue-at-Risk Prioritization

First-in-first-out and revenue-at-risk prioritization differ in what they protect. First-in-first-out protects the oldest claim; revenue-at-risk protects the most recoverable revenue before its deadline. The table below sets out the operational differences a VP of Revenue Cycle will notice within the first month of switching.

The honest trade-off: revenue-at-risk ordering deliberately lets some denials expire. Those are the ones with low balances, low overturn odds, and missing documentation. First-in-first-out lets denials expire too; it just does not choose which ones.

The 5-Factor Revenue-at-Risk Score

The 5-Factor Revenue-at-Risk Score is an ordering rule that ranks every open denial on payer window, deadline proximity, revenue exposure, clinical readiness, and appeal probability, each scored from the provider's own validated data. The score is recomputed daily. AI's job is the recomputation and the routing; the weighting is a management decision and should be defended as one.

1. Payer window

Payer window is the total number of days the contract or regulation allows for an appeal, and it sets the clock for everything else. Medicare Advantage gives 65 days under CMS rules. Many commercial contracts give 180. Some Medicaid managed care plans give 60 or 90. The field is a fixed lookup by payer and denial type. It is also the field most often missing from the billing system, because it lives in the contract, not the remit.

2. Deadline proximity

Deadline proximity is the share of the payer window already consumed. A denial 50 days into a 65-day window is at 77%; a denial 50 days into a 180-day window is at 28%. The score weights proximity more heavily as it passes 60%, so that claims approaching expiry jump the queue even when their balance is modest. In Assembly's experience the proximity factor is the one that moves recovered revenue fastest in the first 90 days, because it addresses the write-offs that were already happening.

3. Revenue exposure

Revenue exposure is the expected contractual reimbursement on the claim, not the charge amount. Charge-based ranking inflates every claim by the same markup and tells the team nothing. Contract-based ranking needs the payer fee schedule or the historical paid-to-billed ratio for that payer and service line, which is why this factor depends on the master tables described in Assembly's post on why AI on a fragmented RCM workflow makes things worse.

4. Clinical readiness

Clinical readiness is a yes-or-no field: is every document the appeal needs already in the record? A medical necessity denial with the physician note, the order, and the payer policy citation in hand can be appealed today. The same denial with a missing note cannot, no matter how high the balance. Readiness routes the claim: ready claims go to appeal writers; unready claims go to clinical documentation staff with a request, and come back into the queue once the gap closes. Crowe's Q1 2023 data found request-for-information denials ran at 4.8% for commercial payers against 0.4% for traditional Medicare, which is why readiness matters far more on commercial books.

5. Appeal probability

Appeal probability is the historical overturn rate for that payer, denial reason, and service line, taken from the provider's own appeal history. Published rates are a starting point only. Premier's 2024 analysis of 516 hospitals found 54.3% of initially denied private-payer claims were eventually overturned; the April 2026 JAMA study of 51,000 New York appeals found overturn rates rising from 38% in 2019 to about 53% in 2025, with a spread from 36% to 85% depending on the insurer. That spread is the whole point. A single average hides the fact that some payer and reason combinations almost never overturn and others almost always do.

A worked weighting

A reasonable starting weighting, to be tuned against the provider's own recovered revenue after one quarter, is 35% deadline proximity, 30% revenue exposure, 20% appeal probability, and 15% clinical readiness, with payer window acting as the denominator for proximity rather than as a weighted factor itself. The part most people push back on: deadline outweighs dollars. Nearly every team we have watched sorts by balance first, because the biggest number on the screen feels like the biggest problem. A balance-first sort recovers a few large claims and lets dozens of mid-sized claims expire, and the mid-sized claims are where the write-off number actually lives. Sort by proximity first, then exposure, and the write-off line falls before the overturn rate moves.

How Can AI Prioritize a Denial Worklist by Revenue at Risk Without Clean Data?

AI cannot prioritize a denial worklist by revenue at risk without clean data, and a VP of Revenue Cycle should refuse any claim that it can. Three of the five factors (payer window, revenue exposure, appeal probability) come from master tables that most providers have never built; a fourth (clinical readiness) depends on documentation the AI can check for but cannot create. AI's contribution is recomputing and routing at volume, not inventing the inputs.

What the score needs from the data foundation

The score needs a payer table with appeal windows by denial type, a contract table with expected reimbursement by payer and service line, a denial history with outcomes by payer and reason, and a documentation index that says which records are attached to which claim. None of these is exotic. All of them are usually scattered across the billing system, the contract management folder, a clearinghouse portal, and two or three spreadsheets. Experian's 2025 survey found 68% of providers say submitting clean claims is harder than a year ago, and only 14% use AI in claims at all. The gap between those two numbers is the data foundation.

What AI cannot score

AI cannot tell whether a physician's note supports medical necessity under a specific payer's policy; that is clinical judgment and belongs to a nurse reviewer or physician advisor. AI cannot know a payer changed its appeal window last quarter unless someone updated the table. AI cannot recover a claim that was denied because the service was never authorized and the payer's contract bars retroactive authorization. The three-column map in Assembly's first post in this series puts these in the "AI cannot fix" column for a reason, and the worklist redesign does not move them.

When a generic worklist tool is not enough

For a provider with denials spread across a dozen or more payers, a write-off number that has already reached the board, and clinical denials making up a rising share of the total, a generic worklist or a vendor's black-box priority flag is not enough. The answer is a dedicated build that does three things: first, assembles the five inputs as validated fields the provider's own data team can audit, payer by payer; second, publishes the weighting so the VP can defend each number to the CFO and change it when the quarter's results say to; and third, routes claims to the right people (appeal writers, clinical reviewers, clerical staff) rather than presenting one re-sorted list to everyone. A tool that only re-sorts the list has not redesigned anything. It has handed the old workflow a new sort order and called it a day.

How to Redesign the Denial Workflow Around the Score

A denial workflow redesign around the revenue-at-risk score runs as a one-payer pilot, measured on recovered revenue as a share of revenue at risk, before it expands. Start with the payer that has the shortest appeal window and the largest aged balance, because that is where expiring appeals cost the most. Expand one payer at a time as the master tables fill in.

Pick the pilot payer

Choose the payer where the three worst problems overlap: a short window, a high share of clinical denials, and a large balance aged past 90 days. For many providers that is a Medicare Advantage plan, given the 65-day window and the 55.7% denial growth the AHA reported. For a diagnostics or lab enterprise it may be the commercial payer with the highest request-for-information rate. One payer keeps the master tables small enough to validate by hand.

Build the five fields for that payer only

Pull the appeal window from the contract. Build expected reimbursement from the fee schedule or twelve months of paid-to-billed history. Pull overturn rates by denial reason from the provider's own appeal log, falling back to published rates only where the log is thin. Tag clinical readiness from the documentation index. The data team, not the vendor, owns every field. This is the part of the work an AI workflow audit exists to do before anyone automates anything.

Run the score beside the old queue for one cycle

For one full appeal cycle, compute the score daily and show it next to the existing first-in-first-out list without changing who works what. Record which claims the score would have prioritized and what happened to them. This produces the before-and-after the CFO will ask for without risking the current quarter. Then switch the team to the scored order and measure recovered revenue as a share of revenue at risk, by denial reason, against the prior cycle.

Measure what matters

Track four numbers: revenue at risk at the start of the cycle, revenue recovered, revenue expired unworked, and revenue expired after an appeal was filed. The first three move within 60 to 90 days. The last one is where appeal quality lives, and it is the subject of a later post in this series. Overturn rate on its own is not a success metric for the redesign; it can rise while the write-off line also rises, if the team simply appeals fewer claims. Posts on AI use cases in healthcare operations tend to list denial prioritization as a single line item. In practice the measurement design is most of the work, and it is the part that gets skipped.

The Hardest Questions a VP of Revenue Cycle Will Ask

The hardest questions about revenue-at-risk prioritization come from the people who have watched three denial tools fail. They are fair questions. Here is how we would answer them.

"Our vendor already has a priority flag. Why build one?"

Because the flag's logic is not visible, and the inputs behind it are the vendor's, not yours. When the CFO asks why claim A ranked above claim B, "the system scored it higher" is not an answer. A score the data team built from the provider's own tables can be defended line by line. A score with a vendor's weighting cannot, and it cannot be retuned when the quarter's results say the proximity weight is too low.

"If we let low-score denials expire, the board will say we gave up revenue."

The board is already giving up that revenue. It is just happening in arrival order, invisibly. The redesign makes the choice explicit and documents it: these claims expired because the expected recovery was below the cost of working them, and here is the recovered revenue from the claims that were worked instead. Crowe's benchmarking found 31% of commercial inpatient claims unpaid after 90 days against 12% for Medicare; the expiry is happening with or without a scoring rule.

"Isn't this just a report? Where is the AI?"

A static report is a one-time ranking. The denial queue changes every day: documentation arrives, deadlines approach, payers respond, new denials post. Recomputing the score across tens of thousands of open claims every night and routing each one to the right work group is the part that does not scale with people. That is the AI. The weighting, the tables, and the decision to expire a claim remain with the revenue cycle leadership, where they belong. Assembly's post on AI in revenue cycle management legacy systems covers why this layer usually has to sit beside the billing system rather than inside it.

This analysis was developed using methodologies and operating experience from Assembly.

Frequently Asked Questions

Can AI prioritize a denial worklist by revenue at risk?

AI can prioritize a denial worklist by revenue at risk when five fields exist on every denied claim: payer appeal window, days remaining, expected reimbursement, clinical documentation readiness, and the provider's own overturn rate for that payer and reason. AI recomputes the ranking daily and routes claims. Without validated inputs the ranking is unreliable.

What is revenue at risk in a denial queue?

Revenue at risk is the expected reimbursement on a denied claim multiplied by the probability it can still be recovered, discounted by the time remaining before the payer's appeal deadline. Two claims with the same balance differ sharply if one has 12 days left with a low-overturn payer and the other has 170 days with a high-overturn payer.

Why does first-in-first-out fail for denial management?

First-in-first-out fails because the denial queue is longer than the shortest payer appeal window. When the team cannot clear the whole list inside 65 days, arrival order decides which appeals expire. Experian's 2025 survey found 41% of providers see one in ten claims denied, and volumes at that level make arrival-order queues a lottery.

What is the difference between first-in-first-out and revenue-at-risk prioritization?

First-in-first-out protects the oldest claim; revenue-at-risk protects the most recoverable revenue before its deadline. First-in-first-out ignores payer deadlines and documentation status and lets whichever claim sat longest expire. Revenue-at-risk ordering scores deadline proximity, exposure, readiness, and appeal probability daily, and deliberately lets low-value, low-probability denials expire instead.

What are the five factors in the Revenue-at-Risk Score?

The 5-Factor Revenue-at-Risk Score uses payer window, deadline proximity, revenue exposure, clinical readiness, and appeal probability. Payer window is the total days allowed; proximity is the share already consumed; exposure is expected contractual reimbursement; readiness asks whether appeal documentation is in hand; appeal probability is the provider's own overturn rate by payer and reason.

How should deadline be weighted against claim balance?

Deadline proximity should outweigh claim balance in a denial prioritization score. A starting weighting of 35% proximity, 30% revenue exposure, 20% appeal probability, and 15% clinical readiness, tuned after one quarter, works for most providers. Balance-first sorting recovers a few large claims and lets dozens of mid-sized claims expire, which is where the write-off number lives.

What data does a denial prioritization score need?

A denial prioritization score needs four master tables: payer appeal windows by denial type, expected reimbursement by payer and service line, denial history with appeal outcomes by payer and reason, and a documentation index linking records to claims. These usually sit across the billing system, contract folders, clearinghouse portals, and spreadsheets, and the provider's data team must own every field.

What can AI not do in denial prioritization?

AI cannot judge whether a clinical note supports medical necessity under a specific payer policy, cannot know a payer changed its appeal window unless the table is updated, and cannot recover claims denied for missing authorization where the contract bars retroactive approval. Those stay with nurse reviewers, contract managers, and upstream process fixes, not with the worklist.

How long are payer appeal windows?

Payer appeal windows range from about 60 days to a year depending on the payer and contract. CMS rules for Medicare Advantage allow 65 calendar days to request reconsideration, and plans then have up to 60 days to decide payment appeals. Many commercial contracts allow 180 days. A first-in-first-out queue cannot see these differences.

How many denied claims are actually appealed?

Very few denied claims are appealed. KFF's 2024 analysis of ACA marketplace plans found insurers denied about 19% of in-network claims and fewer than 1% of those denials were appealed, while 66% of appeals that were filed were upheld. The revenue in unappealed denials is far larger than the revenue in lost appeals.

What share of denials are overturned on appeal?

Roughly half of appealed denials are overturned, with a wide spread by payer. Premier's 2024 analysis found 54.3% of initially denied private-payer claims eventually paid. The 2026 JAMA study of 51,000 New York cases found overturn rates from 36% to 85% by insurer, which is why provider-specific rates matter more than averages.

Which payer should a denial prioritization pilot start with?

A denial prioritization pilot should start with the payer where a short appeal window, a high share of clinical denials, and a large balance aged past 90 days overlap. For many providers that is a Medicare Advantage plan, given its 65-day window and the 55.7% denial growth the AHA reported for 2022 to 2023.

How do you measure whether denial prioritization worked?

Denial prioritization is measured by recovered revenue as a share of revenue at risk, by payer and denial reason. Track revenue at risk at cycle start, revenue recovered, revenue expired unworked, and revenue expired after appeal. Overturn rate alone is misleading because it can rise while write-offs also rise if the team simply appeals fewer claims.

How often should the denial score be recomputed?

The denial score should be recomputed daily. Deadlines move closer every day, documentation arrives, payers respond, and new denials post overnight. A ranking computed once a week is stale by Wednesday. Daily recomputation across tens of thousands of open claims is the part of the work that does not scale with staff, and it is the part AI handles.

Who should own the denial prioritization weighting?

The VP of Revenue Cycle should own the weighting, with the data team owning the inputs. The weighting is a management decision about which revenue to protect first and must be defensible to the CFO line by line. Vendor-set weightings cannot be defended or retuned, which is the main argument for building the score on the provider's own tables.

What happens to low-score denials under revenue-at-risk prioritization?

Low-score denials are documented and allowed to expire by design. These are claims with low balances, low historical overturn odds, and missing documentation, where expected recovery is below the cost of working them. Under first-in-first-out the same revenue expires invisibly in arrival order. The redesign makes the choice explicit and reports the recovered revenue from claims worked instead.